Core Insights - The company reported a revenue of HKD 944 million for the six months ending June 30, 2025, representing a year-on-year increase of 2.4% [1] - Gross profit reached HKD 294 million, up 1.7% year-on-year [1] - Profit attributable to equity holders increased significantly by 62.4% to HKD 49.94 million [1] - Adjusted profit attributable to equity holders rose by 74.5% to HKD 69.64 million [1] - Basic earnings per share were HKD 0.0411 [1] Revenue Breakdown - The slight increase in total revenue was primarily driven by a growing demand for ophthalmic medical services in the Hong Kong market [1] - Revenue growth from Hong Kong ophthalmic services was partially offset by a decline in revenue from dental and ophthalmic services in Shenzhen due to intense competition [1]
希玛医疗(03309.HK)：上半年纯利为4994.4万港元 同比增加62.4%